Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hyperoxaluria, Primary

• Nedosiran in Pediatric Patients From Birth to 5 Years of Age With PH and Relatively Intact Renal Function
• Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD
• Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients
• A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1
• Long Term Extension Study in Patients With Primary Hyperoxaluria
• A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2
• Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria
• A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1
• Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
• Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia
• An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Patients With Primary Hyperoxaluria Type 1
• A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
• Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1
• Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
• Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate
• Phase 2/3 Oxabact Study
• Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
• Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
• Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria